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HIV is the only retrovirusthat has as ofnow anidentified receptor, the CD4mol-
ecule (1-3), towhich itsoutermembrane glycoprotein (gp110)binds with high affinity
(4, 5). This glycoprotein is produced from the cleavage ofa gp160 precursor gener-
ating gp110 and the gp41 transmembrane protein (6). This receptor/envelope inter-
action occurs in three distinct situations. Envelope gp110 expressed on a viral par-
ticle binds membrane expressed CD4 on target cells (4), controlling the host range
and tissue specificity ofvirus infection (7-9); gp110 expressed on the surface of an
infectedcell, can bind to CD4 expressedon other(s) cell(s), inducing cell fusion and
syncytium formation (10, 11). Finally, CD4 and gp110 can interact within a single
cell, inducing the formation ofimmunoprecipitable gp110-CD4 complexes that are
thoughtto account forthedisappearance ofCD4 from the cell surface ofHIVinfected
cells (7, 12). The presence ofsuch receptor/envelope complexes in infected cells has
been postulated for many other retroviruses, causing the so called "interference"
phenomenon; i.e., cells infected with a given strain of avianleukemia virus (ALV)r
are resistant to infection with other related but distinct strains of this virus (13).
This is commonly viewed as resulting from the occupancy ofthe receptor, used by
both retroviruses, by endogeneouslyproduced envelope ofthe first strain. Sincethe
nature ofthe receptor for these viruses is unknown, it has not yet been possible to
verify this hypothesis. However, modification of the receptor synthesis at the tran-
scriptional or post-transcriptional levels could alsobe involved in down-modulation
ofretrovirus receptor, as it has been proposed for HIV. Hoxie et al. (12) have shown
that CD4+ cells infected with HIV presented decreased levels ofboth CD4 mRNA
and protein as compared with the initial uninfected cells after 2 to 3 mo ofchronic
viral replication. From these experiments, the authors could not discriminate be-
tween regulation ofCD4 gene transcription or selection oflow CD4-expressing sub-
clones, more resistant to HIV cytopathic effect. In contrast, Stevenson et al. (14),
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using a subclone of the CEM line that was resistant to HIV cytopathic effect, pro-
posed that upon HIV replication, a post-transcriptional mechanism affected CD4
protein production but also that of other T cell membrane markers. In both cases,
these studies were conducted in established cell lines and did not necessarily reflect
what really occurred in HIVinfected normal lymphocytes.
We have studied membrane expression and gene regulation of CD4 during acute
HIV replication in normal CD4 lymphocytes as well as in CEM cells and after in-
fection with HIV/vaccinia recombinant viruses (HIV-VV) expressing mutated env
gene. We show that both CD4/gp110 complex formation and the rapid disappear-
ence of CD4 mRNAs account for the modulation of the HIV receptor.
Materials and Methods
Preparation, Infection, and Culture ofCells.
￿
PBMC were obtained from HIV- normal indi-
viduals, using the Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) separation method. When
necessary, PBMC were depleted ofCD8' T lymphocytes by specific cytotoxicity with mAb
IOT8a (Immunotech, Marseille, France) and rabbit complement (Biokar, Pantin, France)
before infection. After cytotoxicity, <1% of CD8' cells remain in the CD4'-enriched PBMC.
The CEM subclone (CEM 13) was isolated after cloning in semi-solid agar of the original
CEM Tlymphoblastoid cell line.
Infection was performed with supernatant of cultured HIV-1-infected PBMC (LAVBRU iso-
late (15), corresponding to the peak of viral production: >5.105 cpm/ml; >105 IDW (16).
PBMC or CD4'-enriched PBMC were suspended for 1 h at 370C (107 cells/0.1 ml HIV su-
pernatant). Normal and infected lymphocytes were adjusted at 106 cells/ml and cultured at
37°C in an atmosphere of 5% C02 in RPMI 1640 supplemented with 10% FCS, 2 mM
glutamine, 1% antibiotics (penicillin, streptomycin, neomycin; Gibco-BRL, Uxbridge, UK)
and 4 wg/ml PHA (PHA-M; Gibco-BRL). On day 3, cells were pelleted and resuspended
in this complete medium containing IL-2 (20 U/ml) instead of PHA. Under these culture
conditions, monocytes and B lymphocytes do not proliferate and at day 5, when we started
analysis, <5% of nonT cells were present in the culture. CEM cells were cultured in the
same medium without PHA and IL-2.
Viral production in the supernatant of HIV-infected cells was determined by particle-
associated reverse transcriptase assay (17) and immunocapture ELISA(ELAVIA; Diagnostics
Pasteur, Marnes-la-Coquette, France) using 10-fold dilutions of cell-free supernatants. Ab-
sorbance (A) was determined with an ELISA-plaque reader (Diagnostics Pasteur) at 492 nm.
Immunofluorescence Analysis.
￿
Control and infected cells (2-5 x 105 cells per staining) were
harvested, rinsed in cold PBS and incubated for 30 min at 4°C with appropriate mAbs diluted
at 1 :100 to 1 :200 in staining buffer (SB) that comprised PBS, 0.5% BSA, and 0.05% sodium
azide. mAbs used were as follows: anti-CD4: Leu3a PE (Becton Dickinson & Co., Mountain
View,CA), T4-FITC (Coulter Corp., Hialeah, FL), OKT4 (Ortho Diagnostic Systems, West-
wood, MA); anti-T cells: T3-RDI (CD3), T11-RD1(CD2), 4134 RDl (CDw29) (Coulter Corp.),
Leu2a (CD8) (BectonDickinson & Co.); anti-HIV: 41-1 (anti-gp41), 110-4(anti-gp110) (Genetic
Systems Corp., Seattle, WA). Unlabeled mAbs (OKT4, 41-1, 110-4) were revealed by sequen-
tial incubation with biotinylated sheep anti-mouse antibodies (Amersham Corp., Bucking-
hamshire, UK) at 1 :25, and phycoerythrin-conjugated streptavidin (Becton Dickinson & Co.)
at 1 :25. When double-color labeling was performed (T4/OKT4, T4/41-1, T4/110-4), control
ascites fluid (Dakopatts, Copenhagen, Denmark) at 1 :25 was added to phycoerythrin-
streptavidin in order to saturate the remaining binding sites of sheep anti-mouse antibodies
before incubation with the second mAb, T4-FITC. After staining, cells were resuspended
in SB containing 1% paraformaldehyde, kept at 4°C, and analyzed together with the FAGS
analyzer (Becton Dickinson & Co.). As described elsewhere (18), volume versus right-angle
light scatter dot plot was used to gate viable cells and exclude debris as well as dead and
giant autofluorescent cells. In initial experiments, the volume-scatter gate was correlated with
propidium iodide staining and encloses a population with <5% of dead cells. FluorescenceSALMON ET AL.
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intensity was then determined within these gated viable cells and plotted in a 3-decade log-
scale. Results are presented as histograms (cell number versus fluorescence intensity) for single-
color staining experiments, or as autoscaled contour maps of cell number in double-color
staining experiments, each axis representing fluorescence intensity in one channel (vertical,
red; horizontal, green).
Cytoplasmic Extracts (Cytodots).
￿
Control and infected cells (2.5 x 105 viable cells as mea-
sured by trypan blue exclusion) were rinsed three times in cold PBS, resuspended in 100 pl
of Tris (10 mM, pH 7.0), 1 mM EDTA, 2 mM Vanadyl ribonucleoside complex (Bethesda
Research Laboratories, Gaithersburg, MD), 0.5% NP-40 (BDH Chemicals,Poole, England)
and vortexed for 5 min on ice. Then, 10 ul of 5 % NP-40 was added, cells were vortexed for
5 min on ice, and nuclei were pelleted by centrifugation at 40C for 10 min at 10 000 g, 100
wl of supernatant was completed with 100 g1 of 12 x SSC (1 x SSC NaCl 0.15 M, 0.015 M
trisodium citrate, pH 7.0) 15% formaldehyde, incubated 15 min at 65°C and spotted on a
nylon membrane (Hybond-N, Amersham Corp.) using the Minifold apparatus (Schleicher
& Schuell, Dassel, Federal Republic of Germany).
Northern Blots.
￿
Total cellular RNA was extracted using the guanidinium thiocyanate/cesium
chloride method (19). After centrifugation, RNA pellets were solubilized in 200 P1 of 10 mM
Tris, 1 mM EDTA, 0.1 17o SDS, pH 7.0, and were precipitated with 2.5 vol ethanol in the
presence of 0,3 M ammonium acetate. Precipitates were washed with 70% ethanol, dried,
and redissolved in 200 ul diethylpyrocarbonate-treated H2O. RNA (10 wg per lane) was dena-
tured for 15 min in 50% formamide, 20 mM Mops, 5 mM sodium acetate, 6% formalde-
hyde, pH 7 .0, at 65°C, and was separated by electrophoresis in 1.1% agarose, 20 MM Mops,
5 mM sodium acetate gels as previously described (19). RNAs were transferred to nylon mem-
branes (Hybond N, Amersham Corp.) using 20x SSC for 12-16 h.
Hybridization, Rehybridization Procedures.
￿
Nylon membranes (cytoplasmic extracts or Northern
blots) were baked for 90 min at 80°C, prehybridized, and hybridized as described elsewhere
(19). Specific probes ofCD4 (pT4B) (3), HIVA (Sac I subclone of %J19) (20), TCRS2 chain
(4131) (21) and P-actin (pAL41) (22) were a-32P-radiolabeled using the random priming
method (Multiprime DNA Labeling Systems; Amersham Corp.). Theirspecific activity ranged
from 5 to 10 x 108 cpm/ug DNA. After hybridization, filters were washed under stringent
conditions (three times in 2 x SSC; 0.1 % SDS at room temperature, and twice for 45 min
in 0.1 x SSC; 0.1% SDS at 65°C), and exposed to XAR5 films (Eastman Kodak Co., Roch-
ester, NY) in Quanta III cassette (DuPont de Nemours, Orsay, France) for 24-48 h. When
necessary, filters were dehybridized for 2 h in 2 mM EDTA, 5 mM Tris, 1 x Denhardt's (0.02 %
Ficoll, 0.02% polyvinyl pyrrolidone, 0.02 % BSA), pH 8.0, at 65°C, washed twice in 2 x SSC,
0.1% SDS, and rehybridized as described above.
Construction ofHIV-Vaccinia Recombinant Viruses.
￿
Manipulation of DNA was performed ac-
cording to standard protocols and oligo-nucleotide-directed mutagenesis of subclones into
M13 vectors was performed essentially as described (23). Construction of HIV-VV was real-
ized as described (24). For HIV-VV 1135 the sequence encoding the signal peptide of the
rabies virus glycoprotein gene (nucleotides [nt] 1-64 in Anilionis et al. [25]) was fused with
the first codons of mature gp110 (nt 5857 in Wain-Hobson et al. [26]) using oligonucleotide-
directed mutagenesis (amino acid sequence at the site of fusion: CFGXNK) and the gp41
transmembrane domain (from nt 7834)was replaced by the rabies glycoprotein counterpart
(nt 1387-1714; junction KIRYVL). The sequence containing the two Lys-Arg cleavage sites
between gp110 and gp41 has been altered from KAKRRVVQREKR to KAQNHVVQNEHQ
(nt 7279-7314). HIV-VV 1138 is equivalent to 1135 except that the sequences corresponding
to gp110 and the NH2-terminal hydrophobic domain of gp41 have been removed by oligo-
nucleotide-directed deletion (nt 5857-7398; junction CFG.QAF).
Infection with HIV-Vaccinia Recombinant Viruses.
￿
PHA-stimulated PBMC or CD4'-enriched
lymphocytes were infected with HIV-VV 1135, or 1138, or the wild-type vaccinia virus for
1 h at 37°C at a multiplicity of infection of 50 plaque-forming units (PFU)/cell. Cells were
harvested at various times (see Fig. 3) and investigated for membrane proteins as described
for HIV-infected cells. The efficiency ofinfection was monitored by immunofluorescence on
fixed cells with antivaccinia mouse sera.1956
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Results
Infection of stimulated CD4+-enriched lymphocytes with HIVcontaining super-
natant induces virus replication that usually becomes detectable after a few days
and peaks between day 6 and 8. The cell viability in the culture, as assessed by vital
dye staining, begins to decrease within a day after initial viral detection. After the
peak ofviral replication, all cells ultimately die. To analyze the modification ofcell
surface marker expression during HIV replication, at a time when viral proteins
are synthesized, itis thereforenecessary todiscriminate viable fromdeadcells. This
canbe routinely achieved by using a cell analyzer: viable cells can be distinguished
from dead cells and debris on the basis oftheir volume and right-angle light scatter
values (18). Using these two parameters, a gate can be drawn around the living cells
cluster. Unlike dead cells, such gated cells exclude propidium iodide, a fluorescent
vital dye, and are not stained by irrelevant antibodies. Thus, even at the time when
massive death occurred in the infected cell culture, specific fluorescence could still
be analyzed in the remaining viable gated cells, as shown in Fig. 1. In this experi-
ment, till day 6 ofthe culture, most cells are viable. A day later, after the first detec-
tion ofreverse transcriptase (RT) in the culture supernatant, the number of viable
cells progressively decreased, as shown by both the scatter-volume dot plot and the
count of cells excluding trypan blue. We have analyzed the expression of the CD4
molecule within the gated cell population using Leu3a mAb, and as a control we
analyzed the expression of the CDw 29 molecule (27) detected by the mAb 4B4.
We often used this mAb because CDw29 is also highly expressed on the CD4+
CEM line for which we performed similar experiments. Throughout the culture
time, no gross modification of CDw29 expression could be observed. On the con-
trary, gated cells expressing Leu3a gradually decreased in number andwere almost
absent at the end of the experiment. The rapidity of the appearance of these
Leu3a- ,4B4+ viable cells, as well as the absence of detection of CD8+ cells (data
not shown), rules out the possible emergence of a population of CD4- con-
taminating cells. Thus, loss of Leu3a staining could not be explained only by the
death of HIV-replicating CD4+ cells.
Co-expression ofgp110 and CD4 on HIVReplicating CD4+ Cells.
￿
To more precisely
studymodulation ofCD4atthe surface ofHIV-replicatingcells weperformed double-
staining of CD4+ enriched cells that were infected with HIV. Cells were labeled
either with anti-gp41 or anti-gp110 mAbs or with different mAbs recognizing the
CD4 molecule. Recently, amino acid substitution in the CD4 molecule allowed the
localization of the epitopes recognized by the anti-CD4 mAbs as well as the HIV
bindingsite. Leu3a(Becton Dickinson& Co.) andT4 (Coulter Immunology) recog-
nize epitopes in the very vicinity or at the HIV binding site (28). They block HIV
bindingtoCD4and, reciprocally HIV blocks theirbindingtoCD4 (4, 8, 29). OKT4
(Ortho Diagnostic Systems) recognizes an epitope more distant from HIV binding
site and it does not interferewith the interaction between gp110 and CD4 (4, 8, 29).
Using double-color staining procedure with OKT4, anti-gp41, or anti-gp110 mAbs
on one hand (red, vertical axis) and T4 mAb on the other hand (green, horizontal
axis), and after gating using volume-scatter dot blot as described in Fig. 1, we ob-
served the emergence of three distinct populations of cells from the initially
T4`OKT4'gpll0- lymphocytes (Fig. 2): (a) gp110+OKT4+T4+ cells; (b)
gp110+OKT4+T4- cells; and (c) gp110+OKT4-T4- cells. Until day 4, infected cellsSALMON ET AL,
Fm=E I,
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CHI death and CD4expression during acute HIV replication in normal lympho-
cytes. PMBC were depleted of CD8' cells, infected with HIV, and cultured as described in
Materials andMethods. At the indicated times, (A)RT activity in the supernatant, percentage
of viable cells (trypan blue exclusion), cell surface labeling with Leu3aand 4114 mAbs andQ
cytoplasmic extracts were performed . (A)UsingaFAGS, viable cellswere first gated on the basis
oftheir volume and scatter values(polygonal cluster in the dot-plot representation) as described.
All samples were analyzed at thesame time. Fluorescence wasanalyzed within these gated cells
and represented as histograms: fluorescence (3-decade logarithmic scale) versus cell number.
Fluorescence meansofnegative controls are comprised in the first decade (not shown). (B) Cyto-
plasmic dots spotted on nylon membranes, corresponding to 2.5 x 10 5 viable cells, were sequen-
tially hybridized with CD4, P-actinand HIV probes andautoradiographed for48, 24, and24 h,
respectively,
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FIGURE 2 .
￿
Coexpression ofCD4 and HIVglycoproteins at the surface ofHIVinfected lympho-
cytes . CD4+ enriched lymphocytes were infected and cultured as described in Fig. 1 . At the in-
dicated times, (A) cell surface staining, (8) viral production in the supernatant (immunocapture
ELISA), percentage of viable cells ("pan blue exclusion), and (C) cytoplasmic extracts were
performed as described in Materialsand Methods . (A) Infected cells (indicated time)andnonin-
fected cells (day 5) were monitored for cell surface markers . Staining with OKT4 (CD4), 41-1
(gp41), and 110-4 (gp110) mAbs wasanalyzed in the red channel (phycoerythrin, vertical axis) .
T4 (CD4)was analyzed in the green channel (fluorescein, horizontal axis). Before fluorescence
analysis, cells were gatedon the basis oftheirvolume and right-angle light scatter as described
in Fig. I (not shown). Clusters represent auto-scaled contour graphs ofcell number,and fluores-
cence intensitywas plotted in 3-decade logarithmic scales. Quadrantswere set usingnoninfected
cells (day 5) stained with control antibodies (left) : biotinylated sheep anti-mouse + phycoerythrin-
streptavidin (spe) (red negative, green negative), Leu3a (red positive, green negative), and T4
(red negative, green positive). (C) Cytoplasmic dots on nylon membranes corresponding to 2.5
x 105 viable cells were hybridized with CD4, HIV and p-actin probes . CD4 and HIV probing
were performed sequentially on the same filter. R-actin probingwasperformed on an indepen-
dent filter. Autoradiography times were 48, 24, and 24 h, respectively.
kept their original gp110-OKT4'T4' phenotype. On day 5, a significant popula-
tion ofgp110+OKT4+T4' cells could be detected, few syncytia were noted and viral
antigens detected by ELISA appeared in the supernatant . On day 6, at the time
when significant loss of viability in the culture was observed, most cells wereSALMON ET AL .
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gp110+OKT4+T4 - while some were already gp110+OKT4-T4- . At this time gp41
appeared at the cell surface. Subsequently, this latter population increasedand cells
finally died. In these experiments, the expression of control antigens CD2 and 4B4
remainedunchanged at the cell surface of gated cells (data not shown) . The almost
complete disappearance ofT4 staining in the face of the persistent OKT4 expres-
sion indicated that CD4 molecule was still present at the lymphocyte membrane
at this time of viral replication (day 6), but in a configuration in which the epitope
recognized by T4 mAb was no longer accessible . This, and co-expression of gp110,
argued for the existence ofCD4in a complexedform with gp110 . Indeed, gp110 binding
to CD4 during adsorption of inactivated virions, or after incubation with purified
gp110, induces similar modification of OKT4a but not of OKT4 staining (4, 30),
andHIV gp/CD4 complexes can be immunoprecipitated byOKT4 but notOKT4a
mAbs (12) .
CD4 Expression after HIV-Vaccinia Recombinant Virus Infection .
￿
It was not possible
from these experiments to determine to what extent gp110 was produced by infected
cells and presented to their membrane before the assembly of viral particles, or was
in the form of soluble gp110 passively adsorbed on uninfected CD4+ cells, or per-
haps at the surface ofmature virions that were in the process ofinfecting new cells,
both cases being responsible for CD4 masking (8, 30, 31) .
To demonstrate that interaction betweenCD4 andHIV envelope actually occurred
in each individual cell, we used vaccinia recombinant virus . Infection with such viruses
allows theexpression of foreign genes in vitro as well as in vivo (32) and is currently
the best way to express high levels of normal or mutatedHIVena gene products in
the infected cells (10, 11, 24, 33, 34) . Initial experiments with normal ena gene had
shown an important shedding of gp110 from the cell surface ofHIV-VV-infected cells
(24) . We thereforeused aconstruction designed to optimize expression ofHIV envelope
at the cellmembrane . In this construction (1135), the twocleavage sites that generate
gp110 and gp41 from the gp160 precursor (Fig . 3 A) were inactivated by amino acid
substitutions (see Materials and Methods) . The signal peptide, the transmembrane
andintracytoplasmic regionsofHIV were replaced by thoseof rabies virusenvelope
glycoprotein . As control, we used a similar construction containing only the gp41
external region (1138) and also the wild-type vaccinia virus . High multiplicity of
infection (50 PFU/cell) allowed synchronous, rapid, and massive infection ofmore
than 90% of the cells, as determined by immunofluorescence with specific mouse
sera to vaccinia antigens, further leading to cell death within 24-36 h . We first per-
formed a time course experiment (Fig . 3 B) in which normal PBMC were infected
by the two recombinants. Stainings using 4B4 and Leu3a mAbs were analyzed as
described for HIV infection . While expression ofa control molecule like CDw29
remained unchanged until 24 h after infection, a progressive decrease of Leu3a ex-
pression was observed after infection withHIV-VV 1135 but not with HIV-VV 1138 .
This effect, which appeared as early as 6 h after infection, could be clearly seen at
16 h and was almost complete at 24 h. Subsequent experiments were performed be-
tween 20 and 24 h after infection . We then analyzed expression of CD4 and HIV
envelope after HIV-VV infection as we did afterHIV infection (Fig . 3 C) . Infection
with the wild-type vaccinia or HIV-VV 1138 did not modify membrane expression
of either Leu3a or OKT4 epitopes of theCD4 molecule, nor did they modify the
expression ofcontrol molecules likeCDw29 orCD3 (data not shown) . Infectionwith1960
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FIGURE 3 .
￿
Expression ofCD4and HIVglycoproteins after infection with vaccinia recombinant
viruses expressing HIVenv gene products . (A) HIV eno gene (HIV) and sequences inserted in
the thymidine kinase gene of HIV-VV 1135 (1135) andHIVVV 1138 (1138) are represented . HIV
sequences (clearboxes) and rabies virus sequences (shadedboxes) were fused as described in Materials
and Methods . The whole gp41 sequence comprised boxesnamed gp41' (NHZ-terminal and ex-
ternal regions),TM (transmembrane region), and CYT(intracytoplasmic region) . In HIVVV
1138, gp41"" represents the external region of gp41 fused with rabies glycoprotein signal peptide
(SP, left) andtransmembrane (TM) and cytoplasmic(CYT) rabies glycoprotein regions. Arrows
indicate the two cleavage sites described in text and Materials andMethods . (B)At the indicated
times, PBMC infected with HIV-VV 1135 or HIV-VV 1138 were labeled with Leu3a and 4B4SALMON ET AL.
￿
1961
HIV-VV 1135 led to the expression ofthe hybrid envelope onto the cell surface that
can be detected with anti-gp110mAb. This was accompanied by the complete disap-
pearance of the Leu3a epitope, while the reduction of OKT4 staining was about
fourfold. In this experiment, a twofold decrease of 4B4 could be observed, a
phenomenon that was not, however, consistently observed (Fig. 3 B). Since HIV
glycoprotein produced by HIV-VV 1135, like its analogous construct lacking enve-
lope cleavage sites, is not shed in the culture supernatant (35), itwas concluded that
ineach individual cellthe glycoprotein-CD4 interactionwas mediated by endogene-
ously produced HIV glycoprotein.
CD4 TranscriptsAre Lost during Acute HIVReplication.
￿
During HIV replication, the
decrease and, finally, the complete disappearance ofOKT4 staining strongly sug-
gested thedisappearance ofexisting CD4 moleculesfrom the cell surface. CD4-gp110
complexes could beinternalized or alternatively shed from the cell surface, but this
also suggested a lack ofnew synthesis ofCD4 molecules. One possible mechanism
for the latter assumption could be the impairment ofCD4 gene expression due to
HIV replication. To investigate such a possibility, we analyzed CD4mRNA during
virus replication in Tlymphocytes andCEMcells. Inthe two first experiments(Figs.
1 and 2) cytoplasmic extracts of 2.5 x 105 viable cells were prepared and spotted
on nylon membranes at the times of immunofluorescence staining. Hybridization
with a 0-actin probe demonstrated that similar amounts ofmRNAs were spotted.
CD4 mRNA levels dramatically dropped on day 7 (Fig. 1) or on day 6 (Fig. 2), a
dayafter HIVRNA and viral production could be detected. Wenextlooked atmRNA
levels by Northern blot analysis. Viral production and CD4 membrane expression
were sequentially monitored in cultures ofHIV-infected, oruninfected PBMC con-
taining both CD4+ and CD8' cells. Less than 47o ofCD4- CD8- cells could be
detected throughout the culture period ofcontrol uninfected cells (Fig. 4). On the
contrary, a significant proportion of CD4-CD8- cells emerged in the infected cul-
ture; as demonstrated in the previous experiment, they arise from the originally
CD4+CD8- cells that had lost membrane CD4 upon viral replication. Total RNA
was extracted each day from both infected and uninfected cells and 10 pg were ana-
lyzed by Northern blotting. Compared with 0-actin, CD4 mRNA levels started to
decrease in the infected culture on day 6, a time at which the decrease of CD4+
cells and increase of CD4-CD8- cells was observed. By day 7, when the propor-
tion ofCD4-CD8- cells peaked, reaching approximately the percentage ofcells that
were originally CD4+ and on day 8, CD4 mRNA levels became undetectable.
Later, on day 9, CD4 mRNA remained absent, but at that time, all surviving cells
were of the CD8' phenotype. We next investigated whether this dramatic disap-
pearance ofCD4 mRNA could also be observed in a CD4' Tcell line, using aclone
derivedfrom CEM cells. This CD4 highly expressing clone (CEM 13) acutely repli-
cates HIV and is highly sensitive to its cytopathic effects (Salmon, P, andD. Klatz-
mann, unpublished observations). As shown in Fig. 5, after HIV infection CD4
mAbs and analyzed by FAGS. (C) 20 h after infection with the indicated virus, CD4' -enriched
lymphocytes were labeled with Leu2a (negative control), Leu3a, OKT4, 110-4 (gp110), and 4B4
(positive control) mAbs, and were analyzed by FRCS. For each sample, mean of fluorescence
intensity and the relative fluorescence intensity were shown (calculated as follows): 100 x
[(mAb1135,1135 - Leu2a1135-1138)/(mAbwild type - Leu2a~ild type)] .1962
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FIGURE 4.
￿
CD4mRNA levels during acute HIVreplication in normal lymphocytes . At the in-
dicated times, (A) cells were labeled with Leu2a (CD8) and Leu3a (CD4), (B) RNAs were ex-
tractedand analyzed by Northern blotting, and(C) viral production in the supernatant was de-
termined usingan immunocaptureELISA . (A) Percentages of noninfected (ni) and infected (i)
cells expressing either Leu3a or Leu2a as well as Leu2a- Leu3a cells, are shown . Leu2a- ,
Leu3a- cells arose from Leu2a- ,Leu3a* cells that have lost CD4 membrane molecules upon
HIV replication . (B) Northern blot was performed as described in Materials and Methods, in
both uninfected (-) and infected (+) cells . The nylon membrane was sequentially hybridized
with CD4 and 0-actin probes . Autoradiography times were 48 h .
transcripts were almost undetectable, when no more CD4 molecules were detect-
able on the cell surface as assessed by Leu3a and OKT4 staining . As controls,
0-actin mRNA and a nonstructural protein mRNA coding for the TCR 0 chain
were both present at slightly decreased or comparable amounts, respectively, in in-
fected and uninfected cells . This indicated that CD4 transcript accumulation was
specifically impaired during acuteHIV replication in this cloneofTlymphoblastoid
CEM line as for normal lymphocytes .
Discussion
When we initially reported the selective tropism of HIV for CD4+ T lympho-
cytes (2), we already mentioned the striking disappearance ofCD4 staining on the
cell surface of infected cells . This observation has been reproduced and expanded
and it is now well accepted that normal CD4+ T lymphocytes, orTlymphoblastoid
cell lines, and CD4+ monocyte/macrophages or monocytic cell lines, all lose CD4SALMON ET AL .
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FIGURE 5 .
￿
CD4mRNA levels during acuteHIV replication in aCEM clone. CEM-13 (GEM
line-derived clone, see text)cells were infected and cultured as described in MaterialsandMethods .
(A) At day 9, when viral production peaks (data not shown), cells were labeled with Leu3a and
OKT4 mAbs. Control lines represent fluorescence histograms of cells treated only with biotin-
coupled sheep antimouse antibodies plus phycoerythrin labeled streptavidin. (B) Northern blot
analysis of uninfected (day 0) and infected (day 9) cells . The nylonmembrane was sequentially
hybridized with CD4, TcR 02 chain, and 0-actin probes . RNA from uninfected U937 (a mono-
cytic cell line) was used as negative control forTcR N2 chain signal and positive control forCD4
and 6-actin signals .
expression upon HIV -1 replication (12, 36, 37), but also upon HIV -2 and SIV repli-
cation (37) . However, the mechanism of such a phenomenon is unclear. This could
result from the HIVs cytopathic effect, whichwould first affect cells highly expressing
CD4. Indeed, different CD4+ cell lines or even individual clones from a givenCD4+
cell line appear to display heterogeneous sensitivity to HIV cytopathic effect, which
correlates with the extent of CD4 expression (38) . Impairment ofCD4 expression
at the cell surface could alsobedueto its interactionwith gp110 . Such an interaction
could involve endogeneously produced gp110 (12) or alternatively soluble gp110 that
is known to be released in the culture supernatant (24, 39, 40), or even virion ad-
sorption to the cell membrane . Impairment of transcriptional (12) and post-
transcriptional (14) events in CD4 gene expression have also been proposed as pos-
sible mechanisms . To investigate the mechanism ofCD4loss during HIVinfection,
it was therefore necessary to simultaneously monitor cell death, membrane expres-
sion of both CD4 and gp env, as well as CD4 mRNA amounts .
Although cell death rapidly occurred upon HIV replication in normal CD4+ lym-
phocytes, this could not account for the acute loss of CD4 by this cell population .
While it may be argued that these cells are already "sick" because of virus replica-
tion, we were able to identify a state in which these lymphocytes continued to ex-
press normal amounts ofsomemembrane molecules such as4B4 (which waschosen1964
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because it is alsohighly expressed byCEM cells), orCD3 and CD2 (datanotshown),
while they had almost completely lost CD4 expression, as detected by Leu3a. The
observation of CD4 down-modulation at a time when the cell can exclude a vital
dyedoes notimply, however, that cell death is independent ofCD4 impaired expres-
sion, which actually precedes cell death. Decreased expression ofCD4 afterchronic
infection of established CD4' cells could well be due to the selection, among this
population, ofcells for which the equilibrium between HIV replication and cytopathic
effect allows the emergenceofalow C134-expressingcell population (12). Stevenson
et al. (14), using a subclone ofthe CEM cell line resistant to HIV cytopathic effect
and with low CD4 expression, noted that CD41oss was accompanied by decreased
membrane expression ofT3 (CD3), T11 (CD2), T8 (CD8), and T10 (CD38). This
could indicate a different behavior ofHIV in CD4' normal lymphocytes and cell
lines and prompted us to use normal lymphocytes for subsequent experiments.
HIV gp env detection at the cell surface ofviable infected cells has long been un-
successful, and usually only immunofluorescence offixed cells using HIV' human
serum has been shown. The only cell surface staining with mAbs directed to gp110
has been reported by Lyerly et al. (30). However, in this report, gp110 staining was
weaker on HIVinfected cells than on normal CD4' cells coated with gp110. We have
developed a sensitiveassay usingwell-characterized mAbs(41-1; 110-4) (41) and biotin-
streptavidin amplification. This allowed us to observe that gp110 expression at the
cell membrane precedes its interaction with CD4. The subsequent loss of T4 epi-
topes coexisting with the persistence of OKT4 epitopes is in line with results ob-
tained by others in which binding ofHIV or gp110, respectively, to the target cells
induced the disappearance of Leu3a but not that of OKT4 epitopes (4, 30). This
argues for the presence of CD4/gp complexes at the cell membrane. Hoxie et al.
(12) have shown that such complexes can indeed be immunoprecipitated from HIV
infected cell extracts. They proposed that these complexes were intracytoplasmic
because they couldnot detect membrane CD4 at the time ofimmunoprecipitation.
Although we also have been able to immunoprecipitate such complexes at a time
when we could not detect any membrane CD4 molecules (data not shown), our ob-
servation of the emergence of a T4-OKT4'gp110' cell population indicates that
these complexes are actually present at the cell membrane at an early stage ofHIV
replication. However, it is impossible from these experiments to conclude if they
have been formed at the membrane or in the cytoplasm or both. The observation
that gp110 could first be detected before any change ofLeu3a staining could suggest
that they are in part formed at the membrane.
gp110 and gp41 are not associated by disulfide bonds (4) and it is known that
soluble gp110 is released in the culture supernatant of infected cells (24, 39, 40).
This and the production ofviral particlescould be thecause ofthe CD4/gp110 com-
plex formation. To assess whether these complexes result from the interactionofen-
dogeneously produced proteins, we used the advantage ofinfecting cells with HIV
VV, which allows high expression of normal or mutated env gene products at the
cell surface. However, this system is limited by the rapid cell death induced by vac-
cinia replication. In the LAVHF. isolate both Lys-Arg cleavage sites that can appar-
ently be used to produce gp110 and gp41 from the HIV env precursor gp160 (35)
were inactivated in the construct we used, and actually almost no soluble env could
be detected in cell culture supernatant after infection by HIV-VV 1135. The use ofSALMON ET AL.
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heterogeneous signal peptide transmembrane and cytoplasmic regions didnot affect
the correct expression ofthe construct at the cell membrane (35), which could still
be detected by our mAb against gp110, but also which could effectively bind CD4.
Similarly, HIV-VV 1138 led to a strong expression of recombinant envelope mole-
cules that could be detected by anti-gp41 mAb (data not shown). Using these ex-
perimental infections, wedemonstrated that, intheabsence ofreleased solubleenvelope
orvirions, endogeneouslyproducedena gene product and CD4can associateto form
complexes that are detected at the cell membrane. Whether they are membrane or
cytoplasmic formed cannot be discriminated. Wild-type vaccinia infection, as well
as HIV-VV 1138, induces cell death at a similar rate as that of HIV-VV 1135. The
absence ofany modification ofCD4 expression with these twocontrol infections pro-
vides additional evidence that cell "sickness;' which may precede cell death as de-
tected by vital dye staining, is not responsible for the observed phenomenon.
Our results contrast with those of Stevenson et al. (42). After transfection with
anexpression vector containing the ena gene and aselection gene, theselectedclones
display 50% decrease ofboth OKT4 and OKT4a, compared with the original cells.
However, while these authors could demonstrate cytoplasmic staining of acetone-
fixed cells with a human serum, they did not demonstrate the presence ofcell sur-
face glycoprotein and thus, decreased OKT4 expression in their clones may be the
result of selection.
In both HIV or HIV-VV infection, decrease ofLeu3a by maskingofthis epitope
by ena gene products was followed by a decrease in OKT4 staining. This suggests
the actual diminution ofthenumberofCD4 molecules atthe cell membrane, which
can result from the protein interaction allowing either shedding or internalization
ofsuch complexes. However, after HIV-VV infection, OKT4 reduction isonly par-
tial, varying from 3-10-fold according to the experiments. This may be due to the
rapid cell death induced by vaccinia or it can suggest that additional mechanisms
are responsible forCD4 modulation during HIV replication. For instance, the sole
expression of F (3'orf) gene product can cause the decrease of 30-50% of OKT4
staining. Because F protein presents homologies with oncogenic proteins known to
activate proteinkinase C, ithas been proposedthatF proteincan induce CD4internal-
ization by its phosphorylation (43). In addition, Hoxie et al. (12) have observed a
decrease of CD4 mRNA levels in cells from CD4+ cell lines that survive chronic
HIV replication. In contrast, Stevenson et al. (14) did not observe any important
decrease in CD4 mRNA levels after HIV replication in a CEM clone thatwas resis-
tant to HIV cytopathic effect. In both cases, observations were made on cells resis-
tant to HIV cytopathic effect, and thus behaveddifferently from normal CD4+ lym-
phocytes. For these reasons, we looked to CD4 mRNAduring acute HIV replication
in normal CD4+ lymphocytes and in a CEM clone. We always observed a dramatic
decrease in the level ofthese transcripts in both cases. The kinetics ofthe observed
disappearance ofCD4 mRNAs usually showed thatthe first significant decrease oc-
curred on the day when HIV became detectable either by RNA detection, RT or
antigen measurement, and surface expression ofHIV gp110. Theday after, this dis-
appearancewas almost complete, while atleast 50% ofthe initialcultured cellswere
stillviable. This veryrapiddecrease makes itunlikely that a selectiveprocess occurs,
inwhich cellscontaining veryhigh CD4 mRNA levels would firstdisappear, leaving
a cell population expressing extremely low or undetectable levels ofthese mRNAs.1966
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In these experiments, the number ofviable cells from which we prepared extracts
in the blot experiments was calculated after trypan blue exclusion. Hybridization
with a P-actin probe also provided an internal control for the amount of mRNA
spotted or electrophoresed. In addition, the 1.3-kb TCR 0 chain mRNA, which is
produced after a complex transcriptional and post-transcriptional regulation (44,
45), was normally synthesized in these cells. The mechanism ofdisappearance of
CD4 mRNA has yet to be elucidated. Events preceding cell death could lead to a
more rapid degradation ofCD4 mRNA than ofother mRNAs. Alternatively, viral
proteins could directly or indirectly regulate CD4 mRNA synthesis. It has already
been demonstrated that NFKB, a cellular factor involved in the regulation ofimmu-
noglobulin synthesis, can activate HIV enhancers (46). It would be an interesting
possibility that, on the other hand, viral proteins could regulate the CD4 gene, a
memberofthe immunoglobulin supergene family. Experimentsare currently in prog-
ress to investigate these alternative possibilities.
In any case, at the time viral particles are produced, CD4 molecules are absent
from the cell surface. The question then arose: Why did HIV regulate the level of
its receptor expression both at cellmembrane and mRNAlevels? This phenomenon
is reminiscent ofthe well-described viral interference, inwhich cellsthat arechroni-
cally infected by a virus are protected from reinfection by another distinct strain
that uses the same cellular receptor (13). Similarly, in the myxovirus family, neur-
aminidaseofinfluenzavirus, previously knownas"receptordestroying protein," re-
moves sialic acid from the membrane of the host cell (47) that is used as receptor
by the virus (48). Mutants of influenza virus that possess a non-functional neur-
aminidase are less infectious probably because oftheir reuptake by the remaining
receptors (49). In the case of HIV, virus envelope and receptor are coexpressed by
the infected cell and their cytoplasmic and/or membrane interaction will not allow
the expression of a sufficient amount offree env gene products, possibly decreasing
the production and infectivity of virus particles. A selective advantage could thus
have led HIV, and perhaps other retroviruses, to develop this multiple mechanism
to downregulate its receptor during replication.
Given the nature ofHIV receptor, ifmRNA loss corresponds to an actual regula-
tion of gene expression, such a complete shut-off of CD4 expression suggests the
interestingpossibilitythat HIVcould use mechanisms similar tothose usedinnormal
cellular T cell differentiation during which CD4 and CD8 genes may be sequen-
tially turned on and off(50). Our observations may thus provide new insights into
these mechanisms of regulation.
Summary
UsingmAbsand genomic probe totheCD4 molecule, the HIVreceptor, wedemon-
strated that HIV replication induces the disappearance of its functional receptor
from the cell surface by two distinct mechanisms. First, after being expressed onto
the cellsurface, HIVenvelope gp110 will complex CD4, efficientlymasking theCD4
epitope used by the virus to bind its receptor. This phenomenon occurs on the sur-
face of each infected cell and is not due to the release of soluble gp110; infection
with recombinantHIV/vaccinia viruses expressingamutatedHIVenv gene designed
to prevent gp110 release from the cell surface induces a similar gp/CD4 complexes
formation. Second, virus replication induces adramatic and rapid loss ofCD4 mRNAtranscripts, preventingnewCD4 molecules from being synthesized . These twomech-
anisms of receptor modulation could have been developed to avoid reinfection of
cells replicating the virus as well as to produce more infectious particles . These results
suggest that the classical virus interference documented for other retrovirusesmight
not only bedue to receptor/envelope interaction, but might alsodepend on receptor
gene expression .
We thank P J . Maddon, M . Alizon, S. Alonso, and J . C . Strominger for generous gift of
CD4, HIV, 0-actin, and TCR 02 chain plasmids, respectively ; M . Yagelo for FAGS anal-
ysis, C . Chagas for typing the manuscript, and T. Jouault, P J . Maddon, and I . Lowy for
helpful discussions .
Receivedfor publication 8 August 1988.
SALMON ET AL .
￿
1967
References
1 . Dalgleish, A . G ., P C . L . Beverley, P. L . Clapham, D. H . Crawford,M . F. Greave, and
R . A . Weiss. 1984 . TheCD4 (T4) antigen is an essential component of the receptor for
the AIDS retrovirus . Nature (Loud.). 312 :763 .
2 . Klatzmann, D., E . Champagne, S. Chamaret, J . Gruest, D. Guetard,T. Hercend,J . C .
Gluckman, andL. Montagnier. 1984 . T -lymphocyteT4 molecule behaves as the receptor
for human retrovirus LAV. Nature (Load.) . 312:767 .
3 . Maddon, P J ., D . R . Littman, M . Godfrey, D. E . Maddon, L . Chess, and R . Axel .
1985 . The isolation and nucleotide sequence of acDNA encoding theT cell surface pro-
tein T4 : a new member of the immunoglobulin gene family . Cell. 42:93 .
4 . McDouglas, J . S., M. S . Kennedy, J . M . Slight, S. P Cort, A . Mawle, and J . K . A .
Nicholson . 1986 . Binding ofHTLVIII/LAV to T4' cells by a complex of the 110K viral
protein and the T4 molecule. Science (Wash . DC). 231:382 .
5 . Lasky, L . A .,G . Nakamura, D. H . Smith, C . Fennie, C . Shimasaki,C . Patzer, P Bergman,
T Gregory, and D. J . Capon . 1987 . Delineation of a region of the human im-
munodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4
receptor. Cell. 50:975 .
6 . Veronese, F. D., A . L . de Vico, T D. Copeland, S. Oroszlan, R . C . Gallo, andM . G .
Sarngadharan . 1985 . Characterization of gp41 as the transmembrane protein coded by
the HTLV III/LAV envelope gene . Science (Wash . DC) . 229:1402 .
7 . Klatzmann, D., F . Barre-Sinoussi,M . T. Nugeyre, C . Dauguet, E . Vilmer, C . Griscelli,
F . BrunVezinet, C . Rouzioux, J . C . Gluckman, J . C . Chermann, and L . Montagnier.
1984 . Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer
T lymphocytes. Science (Wash . DC) . 225:59 .
8 . McDougal, J . S., A . Mawle, S . P Cort, J . K . A . Nicholson, G . D. Cross, J . A . Scheppler-
Campbell,D. Hicks, andJ . Sligh . 1985 . Cellular tropism ofthehuman retrovirusHTLV
III/LAV. 1 . Role ofT cell activation and expression oftheT4 antigenj Immunol . 135:3151 .
9 . Nicholson, J . K. A ., G. D. Cross, C . S . Callaway, and J . S. McDougal. 1986. In vitro
infection ofhuman monocytes with human Tlymphotropic virus type III/lymphadeno-
pathy-associated virus (HTLVIII/LAV) . J. Immunol . 137:323 .
10 . Sodroski, J ., W. Chun Goh, C . Rosen, K. Campbell, andW. A . Haseltine. 1986 . Role
of the HTLVIII/LAV envelope in syncytium formation and cytopathicity. Nature (Lond.).
322:470 .
11 . Lifson, J . D., M . B. Feinberg, G. R. Reyes, L . Rabin, B. Banapour, S . Chakrabarti,
B . Moss, F. Wong-Staal, K . S. Steimer, and E . G . Engleman . 1986 . Induction ofCD4-
dependent cell fusion by theHTLVIII/LAV envelope glycoprotein . Nature(Lond). 323:725 .
12 . Hoxie, J . A ., J . D. Alpers, J . L . Raackowski, K . Huebner, B . S . Maggarty, A . J . Cedar-1968
￿
CD4 AND HUMAN IMMUNODEFICIENCY VIRUS
baum, and J. C. Reed. 1986. Alterations in T4 (CD4) protein and mRNA synthesis in
cells infected with HIV. Science (Wash. DC). 234:1123.
13 . Weiss, R. A. 1984. Experimental biology and assay of RNA tumor viruses. In RNA
Tumor Viruses. Vol. 1. 2nd ed. R.. Weiss, N. Teich, H. Vermus, andJ. Coffin, editors.
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 226-240.
14 . Stevenson, M., X. Zhang, and D. J. Volsky. 1987. Down regulation ofcell surface mole-
cules during non cytopathic infection of T-cells with human immunodeficiency virus.
J. Virol. 61:3741.
15 . Barre-Sinoussi, F., J . C. Chermann, F. Rey, M . T Nugeyre, S. Chamaret, J. Gruest,
C. Dauguet, C. Axler-Blin, F. BrunVezinet, C . Rouzioux, W. Rozenbaum, and L. Mon-
tagnier. 1983 . Isolation ofa Tlymphotropic retrovirus from a patient at risk for acquired
immunodeficiency syndrome. Science (Wash. DC). 220:868.
16. McDougal, J. S., S. P Cort, M. S. Kennedy, C. D. Cabridilla, P M. Feorino, D. P. Francis,
D. Hicks, V. S. Kalyanaraman, and L. S. Martin. 1985 . Immunoassay for the detection
and quantitation ofinfectioushuman retrovirus, lymphadenopathy associated virus (LAV).
,I Immunol. Methods. 76:171.
17. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo.
1980. Detection and isolation of type C retrovirus particles from fresh and cultured lym-
phocytes ofa patient with cutaneous Tcell lymphoma. Proc. Natl. Acad. Sci. USA. 77:7415.
18. Saunders, A. M., and C. Chang. 1986. A new immune monitoring system for the deter-
mination of lymphoid cell subsets. Ann. NY Acad. Sci. (Clinical Cytometry). 468 :128.
19. Maniatis, T., E. F. Fritsch, andJ. Sambrook. 1982. Molecular Cloning: A Laboratory
Manual. Cold Springer Harbor Laboratory, Cold Spring Harbor, New York.
20. Alizon, M., P. Sonigo, F. Barre-Sinoussi, J. C. Chermann, P. Tiollais, L. Montagnier,
and S. Wain-Hobson. 1984. Molecular cloning oflymphadenopathy-associated virus. Nature
(Load.). 312:757.
21 . Jones, N., J. Leiden, D. Dialynas, J. Fraser, M. Clarby, T. Kishimoto,J . L. Strominger,
D. Andrews, W. Lane, and J. Woody. 1985. Partial primary structure of the alpha and
beta chains of human tumor Tcell receptors. Science (Wash. DC). 227:311.
22. Alonso S., A. Minty, Y Bourlet, and M. Buckingham. 1986. Comparison ofthree actin-
coding sequences in the mouse. Evolutionary relationships between the actin genes of
warm-blooded vertebrates. J Mol. Evol. 23 :11 .
23. Fritz, H. J. 1985. DNA Cloning. A Practical Approach. Vol. 1. IRL Press, Oxford. 151-163.
24. Kieny, M. P, G. Rautmann, D. Scmitt, K. Dott, S. Wain-Hobson, M. Alizon, M. Girard,
S. Chamaret, A. Laurent, L. Montagnier, and J. P Lecocq. 1986. AIDS virus env pro-
tein expressed from a recombinant vaccinia virus. Biotechnology. 4:790.
25. Anilionis, A., W. H. Wunner, and P. J. Curtis. 1981. Structure of the glycoprotein gene
in the rabies virus. Nature (Land.). 294:275.
26. Wain-Hobson, S., P. Sonigo, O. Danos, S. Cole, and M. Alizon. 1985. Nucleotide se-
quence of the AIDS virus, LAV. Cell. 40:9.
27. Morimoto, C., N. L. Letvin, A. W. Boyd, M. Hagan, H. M. Brown, M. M. Kornacki,
and S. F. Schlossman. 1985. The isolation and characterization ofthe human helper in-
ducer T cell subset. J. Immunol. 134:3762.
28. Peterson, A., and B. Seed. 1988. Genetic analysis ofmonoclonalantibody and HIV binding
sites on the human lymphocyte antigen CD4. Cell. 54:65.
29 . Sattentau, Q; J ., A. G. Dalgleish, R. A. Weiss, and P. C. L. Beverley. 1986. Epitopes
of the CD4 antigen and HIV infection. Science (Wash. DC). 234:1120.
30. Lyerly, H. K., T. J. Matthews, A. J. Langlois, D. P Bolognesi, and K. J. Weinhold.
1987 . Human Tcell lymphotropic virus III glycoprotein (gp120) bound to CD4 deter-
minants on normal lymphocytes and expressed by infected cells serves as target for im-
mune attack. Proc. Natl. Acad. Sci. USA. 84:4601.
31 . Mann, D. L., F. Lasane, M. Popovic, L. O. Arthur, W. Gerry Robey, W. A. Blattner,SALMON ET AL .
￿
1969
and M . J . Newman. 1987 . HTLVIII large envelope protein (gp120) suppresses PHA-
induced lymphocyte blastogenesis . J. Immunol . 138:2640 .
32 . Smith, G. L ., M . Mackett, and B . Moss . 1983 . Infectious vaccinia virus recombinants
that express hepatitis B virus surface antigen . Nature (Lond). 302:490 .
33 . Chakrabarti, S., M . Robert-Guroff, F Wong-Staal, R . C. Gallo, and B . Moss . 1986 .
Expression ofthe HTLVIII envelope gene by a recombinant vaccinia virus . Nature (Load .).
320:535 .
34 . Hu, S., S . G . Kosowski, andJ . M . Dalrymple . 1986 . Expression ofAIDS virus envelope
gene in recombinant vaccinia viruses . Nature (Lond) . 320:537 .
35 . Kieny, M . P., R . Lathe, Y . Riviere, K . Dott, D. Schmitt, M . Girard, L . Montagnier,
and J . P Lecocq. 1988 . Improved antigenicity of the HIV env protein by cleavage site
removal . Protein Engineering . 2 :219 .
36 . Clapham, P . R ., R . A . Weiss,A . G. Dalgleish,M . Exley, D . Whitby, and N . Hogg. 1987 .
Human immunodeficiency virus infection ofmonocytic andTlymphocyytc cells : receptor
modulation and differentiation induced by phorbol ester. Virology. 158:44 .
37 . Sattentau,Q J ., P . R . Clapham, R. A. Weiss, P C . L . Beverley, L . Montagnier, M . F
Al Halabi, J . C . Gluckman, and D. Klatzmann . 1988 . The human and simian im-
munodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their
cellular receptor, the CD4 molecule . AIDS . 2:101 .
38 . Asjo, B ., I . Ivhed, M . Gidlund, S . Fuerstenberg, E. V. Fenyo, K . Nilsson, and H . Wig-
zelle . 1987 . Susceptibility to infection by thehuman immunodeficiency virus (HIV) corre-
lates with T4 expression in a parental monocytic cell line and its subclones. Virology. 157:359.
39 . Montagnier, L ., F . Clavel, B. Krust, S. Chamaret, F. Rey, F Barre-Sinoussi, andJ . C .
Chermann . 1985 . Identification and antigenicity of the major envelope glycoprotein of
lymphadenopathy-associated virus . Virology. 144:283 .
40 . Schneider, J ., O. Kaaden, T . D . Copeland, S . Oroszlan, and G . Hunsmann . 1986. Shed-
ding and interspecies type sero-reactivity ofthe envelope glycopeptide gp120 of thehuman
immunodeficiency virus . J Gen . Virol 67:2533 .
41 . Thomas, E . K .,J . N. Weber, J . McClure, P R . Clapham,M . C . Singhal,M . K . Shriver,
andR .A . Weiss . 1988. Neutralizing monoclonal antibodies to theAIDS virus .AIDS . 2 :25 .
42 . Stevenson, M ., C . Meier, A. M . Mann, N . Chapman, and A . Wasiak. 1988 . Envelope
glycoprotein ofHIV induces interference and cytolysis resistance inCD4+ cells : Mech-
anism for persistence in AIDS. Cell. 53:483 .
43 . Guy, B ., M . P Kieny, Y Riviere, C . Le Peuch, K . Dott, M . Girard, L . Montagnier,
andJ . P Lecocq. 1987 . HIV F/3orfencodes a phosphorylated GTP-binding protein resem-
bling an oncogene product . Nature (Loud.) . 330:266 .
44 . Raulet, D. H ., R . D. Garman, H . Saito, and S. Tonegawa . 1985 . Developmental regula-
tion of Tcell receptor gene expression . Nature (Lond). 314:103 .
45 . Toyonaga, B ., Y Yoshikai, V. Vadasz, B. Chin, and T.W. Mak . 1985 . Organization and
sequences ofthe diversity, joining, and constant region genes of the human Tcell receptor
0-chain . Proc. Natl. Acad. Sci . USA . 82:8624 .
46 . Nabel, G., and D . Baltimore. 1987 . An inducible transcription factor activates expres-
sion ofhuman immunodeficiency virus in T cells. Nature (Loud.). 326:711 .
47 . Stone, J . D. 1947 . Comparison of the action of v . cholerae enzyme and of viruses on
the red cell surface. Aust.J Exp. Biol. Med . Sci. 25 :137 .
48 . Weis, W., J . H . Brown, S. Cusack, J . C . Paulson, J . J . Skehel, and D. C . Wiley. 1988 .
Structure ofthe influenza virus haemagglutinin complexed with its receptor, sialic acid.
Nature (Loud .). 333 :426.
49 . Palese, P, K . Tobita,M . Ueda, and R .W. Compans . 1974. Characterization of tempera-
ture sensitive influenza virus mutants defective in neuraminidase . Virology. 61:397 .
50 . Littman, D. R. 1987 . The structure ofthe CD4 and CD8 genes . Annu. Rev . Immunol . 5:561 .